Table 3.
LUMA No.(%) | LUMB No(%) | HER2 No(%) | Basal No(%) | Hybrid No(%) | UC N0(%) | Total No(%) | |
---|---|---|---|---|---|---|---|
IDC | 6 (3.3) | 27 (14.8) | 29 (15.8) | 20 (10.9) | 16 (8.7) | 85 (46.4) | 183 (79.2) |
ILC | 3 (33.3) | 5 (55.6) | 0 (0) | 0 (0) | 0 (0) | 1 (11.1) | 9 (3.89) |
ISC | 0 (0) | 3 (20.) | 7 (46.7) | 0 (0) | 3 (20) | 2 (13.3) | 15 (6.49) |
Other | 0 (0) | 2 (8.3) | 4 (16.7) | 3 (12.5) | 4 (16.7) | 11(45.8) | 24 (10.38) |
IDC = Invasive ductal carcinoma, ILC = Invasive lobular carcinoma, ISC = In situ carcinoma, LUMA = luminal A, LUMB = luminal B, HER2 = human epidermal growth factor receptor 2, UC = unclassified